Last reviewed · How we verify
NCT05187117
CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners
NA trial testing CAPABLE Family - Open Label Pilot in Dementia, Mild in 74 participants. Completed in 15 April 2024.
15 April 2024
Quick facts
| Lead sponsor | Johns Hopkins University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 74 |
| Start date | 9 March 2022 |
| Primary completion | 15 April 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CAPABLE Family - Open Label Pilot
- CAPABLE Family - Randomized Control Trial
Conditions studied
- Dementia, Mild — all drugs for Dementia, Mild →
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Disability Physical — all drugs for Disability Physical →
- Impairment, Cognitive — all drugs for Impairment, Cognitive →
Sponsor
Johns Hopkins University
Who can join
60 and older, any sex, with Dementia, Mild or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test the adapted protocol, CAPABLE Family which builds upon the evidenced based CAPABLE program to address older adults with co-occurring physical disability and mild cognitive impairment or early stage dementia and the older adults' caregivers. It will consist of two phases - an open label pilot and waitlist control trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05187117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dementia, Mild
Currently open trials in the same condition.
- NCT07083154 — GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) · Phase 3 · recruiting
- NCT06854718 — Pain With Dementia · NA · recruiting
- NCT06928298 — Cognitive Screening Made Easy for PCPs - Administrative Supplement · NA · recruiting
- NCT06584110 — Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers · NA · recruiting
- NCT06444841 — Paper-Based and Smartphone-Based Memory Supports · NA · recruiting
Other Johns Hopkins University trials
Trials by the same sponsor.
- NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
- NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
- NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
- NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
- NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05187117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
- Last refreshed: 17 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing